Osaka, Japan

Takahiro Noda

USPTO Granted Patents = 2 


Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takahiro Noda: Innovator in Influenza Prevention

Introduction

Takahiro Noda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the prevention of influenza virus transmission. With a total of 2 patents, his work focuses on innovative methods to combat viral infections.

Latest Patents

One of Takahiro Noda's latest patents is a compound and method for the prevention of transmission of the influenza virus. This invention relates to a method for preventing transmission, which involves administering an effective amount of a compound to a patient infected with the influenza virus, referred to as the 'index patient'. The compound is designed to reduce the infectivity of the influenza virus in the index patient, thereby lowering the risk of triggering an influenza epidemic or pandemic. The method requires that the compound be administered to at least 10% of all influenza-infected individuals within a city's or country's population.

Career Highlights

Throughout his career, Takahiro Noda has worked with notable companies such as Hoffmann-La Roche Inc. and Shionogi Company Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Takahiro Noda has collaborated with esteemed colleagues, including Takeshi Noshi and Ryu Yoshida. These partnerships have further enhanced his research and development efforts in the field of influenza prevention.

Conclusion

Takahiro Noda's innovative work in the prevention of influenza virus transmission showcases his dedication to improving public health. His contributions through patents and collaborations highlight the importance of research in combating viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…